The Health Weblog
+Oh, and also: She’s a 17-year-old high-school junior and winner of this year’s Google Science Fair Grand Prize.
As if that weren’t enough, BW tried out a bunch of commercially-available Neural Networks and decided they just weren’t accurate enough…
Another hurdle in the hunt for individually-tailored, immune-system-rejection-proof, genome-specific, superhero solutions has been passed
by our old friend,
ACCIDENT!
Researcher Christine Chaffer had been doing experiments on breast tissue, and in the course of her research, noted something odd.
Some of the cells she was studying sunk to the bottom of the vessel and some were…
Blah, blah, blah, blah, blah. YOU ARE NOT READING THIS. YOU ARE STARING AT THE PHOTO ABOVE, AREN’T YOU?
[moving on] Thank GOD there was a study that did not actually appear in the New England Joural of Medecine as far back as 2009 or 1997, that had not actually been conducted over the course of 5 years and 500 participants.
The [ed: best] hoax study [ed: of ALL TIME] asserts that 10 minutes of boob-staring is…
The experimental drug Tykerb has been shown to reduce the spread of breast cancer when combined with Xeloda, in a study led by Dr. Charles Geyer, Jr.
The combination of the 2 drugs almost doubled the delay when compared to trials done on Xeloda alone.
Tykerb belongs to a class of drugs that are more specifically-targeted and kill less…
